Denosumab in osteoporosis management for diabetes patients: insights from clinical trials and explorations for dual benefit

Denosumab in osteoporosis management for diabetes patients: insights from clinical trials and explorations for dual benefit

Saved in:

Bibliographic Details
Main Authors:	Chenyu Huang, Jiahui Dai, Philip K. Lim, Katherine Colcord, William Tang, Luohua Jiang
Format:	Article
Language:	English
Published:	BMC 2024-12-01
Series:	Journal of Translational Medicine
Online Access:	https://doi.org/10.1186/s12967-024-05820-5
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Denosumab is the first gene engineered agent for the treatment of osteoporosis
by: O A Nikitinskaya, et al.
Published: (2012-09-01)

Denosumab and the Rebound Effect: Current Aspects of Osteoporosis Therapy (Review)
by: N. Yu. Velts, et al.
Published: (2024-07-01)

A randomized controlled trial comparing romosozumab and denosumab in elderly women with primary osteoporosis and knee osteoarthritis
by: Yasumori Sobue, et al.
Published: (2025-07-01)

Experience with denosumab therapy for osteoporosis in rheumatoid arthritis patients receiving glucocorticoids
by: I. S. Dydykina, et al.
Published: (2018-06-01)

An Atraumatic Femoral Fracture in a Patient with Rheumatoid Arthritis and Osteoporosis Treated with Denosumab
by: J. Villiers, et al.
Published: (2013-01-01)

Factors influencing therapeutic efficacy of denosumab against osteoporosis in systemic lupus erythematosus
by: Sung-Hwan Park, et al.
Published: (2025-01-01)

Efficacy evaluation of denosumab in the treatment of patients with postmenopausal osteoporosis at high risk of fracture
by: Jing ZHOU, et al.
Published: (2025-02-01)

Adherence to treatment with denosumab, its efficacy and safety in women with postmenopausal osteoporosis in clinical practice
by: N. V. Toroptsova, et al.
Published: (2016-01-01)

Advances in the Study of Denosumab Treatment for Osteoporosis and Sarcopenia in the Chinese Middle-Aged and Elderly Population
by: Li S, et al.
Published: (2024-12-01)

Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective
by: Stuart Silverman, et al.
Published: (2015-01-01)

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
by: A. Sánchez, et al.
Published: (2016-01-01)

Comparative efficacy of teriparatide and bisphosphonates or denosumab vs. teriparatide monotherapy in osteoporosis: a meta-analysis
by: Huan Jin, et al.
Published: (2025-05-01)

Impacts of Prior Anti-Osteoporosis Treatments on Sequential Denosumab Responses in BMD Changes Among Postmenopausal Osteoporosis Women in East China: Real-World Data Analysis
by: Guan G, et al.
Published: (2025-05-01)

Effectiveness of Denosumab in Postmenopausal Osteoporosis Treatment: A 1-yr Follow-up Single-center Study
by: Nihal Tezel, et al.
Published: (2021-12-01)

Combination or sequential teriparatide for osteoporosis treatment in denosumab-users: real-world bone mineral density outcomes
by: Shejil KUMAR, et al.
Published: (2025-06-01)

The Effects of Denosumab Treatment on Pain and Function Beyond Bone Density in Patients With Postmenopausal Osteoporosis: A Prospective Study
by: Miao Zheng, et al.
Published: (2025-06-01)

Comparative evaluation of denosumab efficacy of in patients with rheumatoid arthritis and postmenopausal osteoporosis: results of 1-year study in clinical practice
by: O. V. Dobrovolskaya, et al.
Published: (2019-05-01)

THREE YEARS' EXPERIENCE WITH THE BIOLOGICAL AGENT DENOSUMAB USED TO TREAT WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: EFFICACY, SAFETY AND TREATMENT ADHERENCE
by: N. V. Toroptsova, et al.
Published: (2017-07-01)

The efficacy and safety of denosumab, risedronate, alendronate and teriparatide to treat male osteoporosis: a systematic review and bayesian network meta-analysis
by: Shu Jun Chai, et al.
Published: (2025-06-01)

Exploring Denosumab’s potential in aneurysmal bone cyst treatment: A scoping review
by: Vinesh Sandhu, et al.
Published: (2024-10-01)

Superiority of denosumab over bisphosphonates in preventing and treating glucocorticoid-induced osteoporosis: a systematic review and meta-analysis with GRADE quality assessment
by: Chiao-Ling Chen, et al.
Published: (2024-12-01)

Population pharmacokinetics/pharmacodynamics analysis confirming biosimilarity of SB16 to reference denosumab
by: Seungchan Choi, et al.
Published: (2025-08-01)

Beyond Bone Remodeling: Denosumab’s Multisystemic Benefits in Musculoskeletal Health, Metabolism, and Age-Related Diseases—A Narrative Review
by: Yi-Ting Hung, et al.
Published: (2025-03-01)

Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of male osteoporosis: a systematic review and Bayesian network meta-analysis
by: Liangshi Chen, et al.
Published: (2025-04-01)

Effect of Denosumab or Alendronate on Vascular Calcification: Secondary Analysis of SALTIRE2 Randomized Controlled Trial
by: Jolien Geers, et al.
Published: (2024-09-01)

Effect of a single-dose denosumab on mineral homeostasis in infertile men: insights from a pilot intervention study and a randomized controlled trial
by: Sam Kafai Yahyavi, et al.
Published: (2025-03-01)

Denosumab for treating periprosthetic osteolysis: a feasibility study
by: Michael Axenhus, et al.
Published: (2025-04-01)

Severe Hypocalcemia due to Denosumab in Metastatic Prostate Cancer
by: Mohammed Muqeet Adnan, et al.
Published: (2014-01-01)

Denosumab Related Osteonecrosis of Jaw: a Case Report
by: Marco Vinícius de Sales Lima, et al.
Published: (2018-12-01)

Incidence of Total Knee Arthroplasty in Older Females with Knee Osteoarthritis and Osteoporosis Treated with Denosumab Compared with Those Treated Using Bisphosphonates: A Population-Based Cohort Study
by: Tzai-Chiu Yu, et al.
Published: (2024-12-01)

Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis
by: Ryan Carlisle Egbert, et al.
Published: (2017-01-01)

Case report of hypercalcemia-related kidney complications after discontinuation of denosumab
by: Gerrit van den Berg, et al.
Published: (2025-06-01)

Denosumab-Induced Osteonecrosis of the Jaw with FDG PET/CT imaging features.
by: SALONI RAJKOTIA, et al.
Published: (2024-11-01)

Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate
by: Yazhao Mei, et al.
Published: (2025-05-01)

EFFECT OF DENOSUMAB ON CLINICAL AND RADIOLOGICAL CHANGES IN RHEUMATOID ARTHRITIS: PRELIMINARY RESULTS
by: P. S. Dydykina, et al.
Published: (2015-04-01)

Denosumab as an immune modulator in HER2-negative early breast cancer: results of the window-of-opportunity D-BIOMARK clinical trial
by: Andrea Vethencourt, et al.
Published: (2025-05-01)

Exploring molecular links between obesity and osteoporosis: insights from in-silico analysis and mannose supplementation
by: Remya James, et al.
Published: (2025-08-01)

Role of Denosumab and Zoledronic Acid in Geriatric Hip Fractures – A Comparative Analysis
by: P Madhuchandra, et al.
Published: (2024-01-01)

A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors
by: Mingchuan Zhao, et al.
Published: (2025-04-01)

Atypical femur fracture in two patients treated with denosumab: case reports of a patient undergoing maintenance hemodialysis and a kidney transplant recipient, with a literature review of the denosumab used to treat these patients
by: Ryoichi Miyazaki, et al.
Published: (2024-12-01)